Revised SPC: Eylea (aflibercept) 40mg/ml solution for injection in a vial
SPC updated to include retinal haemorrhage as a very common adverse effect.
Source:
electronic Medicines compendium
SPC updated to include retinal haemorrhage as a very common adverse effect.
electronic Medicines compendium